Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Intrinsic Value
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. [ Read More ]
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 13.36 HKD. Compared to the current market price of 9.57 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 28%.
Valuation Backtest
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Run backtest to discover the historical profit from buying and selling Beijing Tong Ren Tang Chinese Medicine Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Balance Sheet Decomposition
Beijing Tong Ren Tang Chinese Medicine Co Ltd
| Current Assets | 3.8B |
| Cash & Short-Term Investments | 2.4B |
| Receivables | 423m |
| Other Current Assets | 1B |
| Non-Current Assets | 590.1m |
| Long-Term Investments | 59.8m |
| PP&E | 436.8m |
| Intangibles | 56.4m |
| Other Non-Current Assets | 37.1m |
| Current Liabilities | 329.9m |
| Accounts Payable | 422.4m |
| Accrued Liabilities | 65.2m |
| Other Current Liabilities | -157.7m |
| Non-Current Liabilities | 238m |
| Long-Term Debt | 75.4m |
| Other Non-Current Liabilities | 162.6m |
Earnings Waterfall
Beijing Tong Ren Tang Chinese Medicine Co Ltd
|
Revenue
|
1.5B
HKD
|
|
Cost of Revenue
|
-477.7m
HKD
|
|
Gross Profit
|
1B
HKD
|
|
Operating Expenses
|
-428.9m
HKD
|
|
Operating Income
|
618.4m
HKD
|
|
Other Expenses
|
-78m
HKD
|
|
Net Income
|
540.4m
HKD
|
Free Cash Flow Analysis
Beijing Tong Ren Tang Chinese Medicine Co Ltd
| HKD | |
| Free Cash Flow | HKD |
Profitability Score
Profitability Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 15.78 HKD with a low forecast of 12.98 HKD and a high forecast of 19.48 HKD.
Shareholder Return
Price
Beijing Tong Ren Tang Chinese Medicine Co Ltd
| Average Annual Return | 4.52% |
| Standard Deviation of Annual Returns | 48.21% |
| Max Drawdown | -46% |
| Market Capitalization | 8.1B HKD |
| Shares Outstanding | 837 100 032 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Contact
IPO
Employees
Officers
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 13.36 HKD.
Compared to the current market price of 9.57 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 28%.
You don't have any saved screeners yet
